Back to results
US 2003/0114504 A1Published application
Compositions and methods for the treatment of cancer
OwnerKevin R. Webster, Spencer David Kimballinventors
Life of this patent
Estimating the term…
Abstract
The compounds of the invention are protein kinase inhibitors and are useful in the treatment of proliferative diseases. Compositions and methods are provided for the synergistic treatment of proliferative disorders.
Claims46
A method for the treatment of proliferative diseases, including cancer, which comprises administering to a mammalian specie in need thereof a therapeutically effective amount of (1) at least one anti-proliferative agent(s) and (2) a compound of Formula I:
- 3
- and pharmaceutically acceptable salts, wherein:
- R1 and R2 are, independently, hydrogen, fluorine or alkyl;
- R3 is aryl or heteroaryl
- R4 is hydrogen, alkyl, cycloalkyl, aryl, cycloalkylalkyl, arylalkyl, heteroaryl, heteroarylalkyl, heterocycloalkyl, heterocycloalkylalkyl;
- or
- CO-alkyl, CO-cycloalkyl, CO-aryl, CO-alkyl-cycloalkyl, CO-alkyl-aryl, CO-heteroaryl, CO-alkyl-heteroaryl, CO-heterocycloalkyl, CO-alkyl-heterocycloalkyl;
- or
- CONH-alkyl, CONH-cycloalkyl, CONH-aryl, CONH-alkyl-cycloalkyl, CONH-alkyl-aryl, CONH-heteroaryl, CONH-alkyl-heteroaryl, CONH-heterocycloalkyl, CONH-alkyl-heterocycloalkyl;
- or
- COO-alkyl, COO-cycloalkyl, COO-aryl, COO-alkyl-cycloalkyl, COO-alkyl-aryl, COO-heteroaryl, COO-alkyl-heteroaryl, COO-heterocycloalkyl, COO-alkyl-heterocycloalkyl;
- or SO2-alkyl, SO2-cycloalkyl, SO2-aryl, SO2-alkyl-cycloalkyl, SO2-alkyl-aryl, SO2-heteroaryl, SO2-alkyl,- heteroaryl, SO2-heterocycloalkyl, SO2-alkyl-heterocycloalkyl;
- or
- C(NCN)NH-alkyl, C(NCN)NH-cycloalkyl, C(NCN)NH-aryl, C(NCNNH)-alkyl-cycloalkyl, C(NCN)NH-alkyl-aryl, C(NCN)NH-heteroaryl, C(NCN)NH-alkyl-heteroaryl, C(NCN)NH-heterocycloalkyl, C(NCN)NH-alkyl-heterocylcoalkyl;
- or
- C(NNO,)NH-alkyl, C(NNO,)NH-cycloalkyl, C(NN0,) NH-aryl, C(NNO.)NH-alkyl-cycloalkyl, C(NNO,)NH-alkyl-aryl, C(NNO,)NH-heteroaryl, C(NNO,)NH-alkyl-heteroaryl, C(NNO,)NH-heterocyloalkyl, C(NNO,)NH-alkyl-heterocycloalkyl;
- or
- C(NH)NH-alkyl, C(NH)NH-cycloalkyl, C(NH)NH-aryl, C(NH)NH-alkyl-cycloalkyl, C(NH)NH-alkyl-aryl, C(NH) NH-heteroaryl, C(NH)NH-alkyl-heteroaryl, C(NH)NH-heterocycloalkyl, C(NH)NH-alkyl-heterocycloalkyl;
- or
- C(NH)NHCO-alkyl, C(NH)NHCO-cycloalkyl, C(NH) NHCO-aryl, C(NH)NHCO-alkyl-cycloalkyl, C(NH)NHCO-alkyl-aryl, C(NH)NHCO-heteroaryl, C(NH)NHCO-alkyl-heteroaryl, C(NH)NHCO-heterocylcloalkyl, C(NH)NHCO-alkyl-heterocycloalkyl;
- or
- C(NOR6)NH-alkyl, C(NOR6)NH-cycloalkyl, C(NOR6) NH-aryl, C(NOR6)NH-alkyl-cycloalkyl, C(NOR6)NH-alkyl-aryl, C(NOR6)NH-heteroaryl, C(NOR6)NH-alkyl-heteroaryl, C(NOR6)NH-heterocylcoalkyl, C(NOR6)NH-alkyl-heterocycloalkyl;
- R5 is hydrogen or alkyl;
- R6 is hydrogen, alkyl, cycloalkyl, aryl, cycloalkylakyl, arylalkyl, heteroaryl, heteroarylalkyl, heterocycloalkylalkyl;
- heterocycloalkyl or
- m is an integer of 0 to 2;
- and
- n is an integer of 1 to 3.
25 more elements
Dependencies are inferred from the claim text.